Segment, Customer and Geographical Reporting (Tables)

3 Months Ended

Dec. 31, 2017

The Company’s segment information for the three months ended December 31, 2017 and 2016 is summarized below:

Results of Operations for the Three Months Ended December 31,
2017
	Optics			Contract Research			Biomedical		Total
Revenue	$	4,942,000		$	4,247,000		$	-	$	9,189,000
Gross profit		1,724,000			1,851,000			-		3,575,000
GM %		35	%		44	%		-		39	%
Operating expenses		1,576,000			1,723,000			445,000		3,744,000
Operating income (loss)		148,000			128,000			(445,000)		(169,000)

Depreciation and amortization		231,000			65,000			3,000		299,000
Capital expenditures		590,000			19,000			16,000		625,000

Intangibles, net		453,000			188,000			337,000		978,000
Goodwill		1,012,000			4,939,000			-		5,951,000
Total assets	$	18,969,000		$	8,114,000		$	614,000	$	27,697,000

Results of Operations for the Three Months Ended December 31,
2016
	Optics			Contract Research			Biomedical		Total
Revenue	$	4,405,000		$	4,738,000		$	-	$	9,143,000
Gross profit		1,574,000			1,951,000			-		3,525,000
GM %		36	%		41	%		-		39	%
Operating expenses		1,328,000			1,740,000			381,000		3,449,000
Operating income (loss)		246,000			211,000			(381,000)		76,000

Depreciation and amortization		234,000			74,000			3,000		311,000
Capital expenditures		91,000			-			20,000		111,000

Intangibles, net		474,000			222,000			337,000		1,033,000
Goodwill		883,000			4,939,000			-		5,822,000
Total assets	$	18,785,000		$	8,407,000		$	1,060,000	$	28,252,000

Revenue by geographic location in total and as a percentage of total revenue, for the three months ended December 31, 2017 and 2016 are as follows: